To The Moon

As of the close on Friday, $S&P/ASX 200(XJO.AU)$ closed at 7,701.70 on Friday, down 0.42% in the past 5 days.

1. $TELIX PHARMACEUTICALS LTD(TLX.AU)$ +17.32%

• The Telix Pharmaceuticals Ltd share price is racing higher this week.

• Investors are bidding up the Telix Pharmaceuticals share after the company announced positive results from its ProstACT SELECT clinical cancer trial.

• The Telix Pharmaceuticals share price is up a whopping 69% so far in 2024. But it could well have further to run. Following on today's announcement, Wilsons has placed a $20.00 price target on Telix Pharmaceuticals shares. That represents a potential 17% upside from current levels.

2. $ALUMINA LTD(AWC.AU)$ +8.91%

• Alumina Limited has released an update, which drive the stock price higher.

• State Street Corporation has emerged as a substantial holder in Alumina Limited, acquiring a 5.13% stake with 148,819,232 ordinary shares as detailed in a recent disclosure. The acquisition, which solidifies State Street Corporation’s influence in the company, was made official on 28th May 2024.

3. $POLYNOVO LTD(PNV.AU)$ +8.17%

• PolyNovo has recently broken into profitability so their prior investments seem to be paying off. About five years ago the company was generating losses but things have turned around because it's now earning 2.0% on its capital. Not only that, but the company is utilizing 143% more capital than before.

• Since the stock has returned a staggering 435% to shareholders over the last five years, it looks like investors are recognizing these changes.

4. $DATA#3 LIMITED(DTL.AU)$ +6.69%

• Data#3's stock is up by a considerable 6.7% over the past week. As most would know, fundamentals are what usually guide market price movements over the long-term.

• To begin with, Data#3 has a pretty high ROE which is interesting. Second, a comparison with the average ROE reported by the industry of 6.4% also doesn't go unnoticed by us. This probably laid the groundwork for Data#3's moderate 17% net income growth seen over the past five years.

• In total, it does look like Data#3 has some positive aspects to its business. Namely, its high earnings growth, which was likely due to its high ROE. However, investors could have benefitted even more from the high ROE, had the company been reinvesting more of its earnings.

5. $NRW HOLDINGS LTD(NWH.AU)$ +5.84%

• The market is a voting machine in the short term, but a weighing machine in the long term, so share price follows earnings per share (EPS) eventually. Therefore, there are plenty of investors who like to buy shares in companies that are growing EPS. Impressively, NRW Holdings has grown EPS by 19% per year.

• NRW Holdings did well to grow revenue over the last year, EBIT margins were dampened at the same time. So it seems the future my hold further growth, especially if EBIT margins can stabilize.